Is Akari Therapeutics, Plc (AKTX) a Buy, Sell, or Hold?
NASDAQ : AKTX
Akari Therapeutics, Plc — Competitors
$8.94 USD
-$0.36 (-3.87%)
- Volume
- 21.23K
- Average Volume
- 794.36K
- Market Capitalization
- $10.23M
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- $30.00
- Year High
- $49.60
- Year Low
- $3.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.27
AKTX vs. The Competition
| Properties | AKTX | CDT | DRMA | MSPR |
|---|---|---|---|---|
| Market Cap | $10.23M | $1.47M | $886.02K | $1377 |
| Shares Outstanding | $1.14M | $485.83K | $681.56K | $13.77M |
| P/E Ratio | -0.01 | -0.09 | -0.24 | -0.0 |
| EPS | -1333.08 | 42.65 | -1.84 | -0.34 |
| Day Low | 8.94 | 2.9201 | 1.245 | 0.000099999997 |
| Day High | 9.235 | 3.335 | 1.32 | 0.01 |
| Year Low | 3.015 | 2.9201 | 1.1 | 0.000099999997 |
| Year High | 49.6 | 4268 | 7.33 | 7.49 |
| Average Price 50 | 11.5754 | 8.2409 | 1.2674 | 0.02158 |
| Average Price 200 | 13.34109 | 272.21072 | 1.98079 | 0.18755 |
| Volume | 21233 | 25605 | 47919 | 11215 |
| Average Volume | - | - | - | - |